These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 28542740

  • 81. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY.
    J Exp Clin Cancer Res; 2015 Aug 22; 34(1):86. PubMed ID: 26297223
    [Abstract] [Full Text] [Related]

  • 82. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
    Pang Y, Holmes MV, Chen Z, Kartsonaki C.
    J Gastroenterol Hepatol; 2019 Feb 22; 34(2):330-345. PubMed ID: 30550622
    [Abstract] [Full Text] [Related]

  • 83. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.
    Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.
    Br J Cancer; 2011 Nov 22; 105(11):1733-40. PubMed ID: 22045190
    [Abstract] [Full Text] [Related]

  • 84. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
    Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SM.
    J Natl Cancer Inst; 2017 Apr 01; 109(4):. PubMed ID: 28376157
    [Abstract] [Full Text] [Related]

  • 85. Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer.
    Cheng J, Yang A, Cheng S, Feng L, Wu X, Lu X, Zu M, Cui J, Yu H, Zou L.
    Med Sci Monit; 2020 Jun 03; 26():e923444. PubMed ID: 32487978
    [Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.
    J Thorac Oncol; 2011 Mar 03; 6(3):482-8. PubMed ID: 21258252
    [Abstract] [Full Text] [Related]

  • 88. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N, Wang L, Yang Y, Gong L, Xiao B, Liu X.
    Biochem Biophys Res Commun; 2017 Nov 25; 493(3):1322-1328. PubMed ID: 28986250
    [Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.
    Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN, Pass HI.
    J Thorac Oncol; 2013 Sep 25; 8(9):1156-62. PubMed ID: 23945385
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F, Li C, Zhang X, Peng W, Wen T.
    Biomed Pharmacother; 2019 Nov 25; 119():109424. PubMed ID: 31521891
    [Abstract] [Full Text] [Related]

  • 93. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X, Ren H, Zhao T, Ma W, Dong J, Zhang S, Xin W, Yang S, Jia L, Hao J.
    Oncotarget; 2016 Mar 22; 7(12):13717-29. PubMed ID: 26872370
    [Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 96. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E, Liu HN, Shen XZ, Liu TT.
    J Dig Dis; 2018 Jul 01; 19(7):404-410. PubMed ID: 29952077
    [Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
    Mellby LD, Nyberg AP, Johansen JS, Wingren C, Nordestgaard BG, Bojesen SE, Mitchell BL, Sheppard BC, Sears RC, Borrebaeck CAK.
    J Clin Oncol; 2018 Oct 01; 36(28):2887-2894. PubMed ID: 30106639
    [Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100. Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patients.
    Joshi GK, Deitz-McElyea S, Johnson M, Mali S, Korc M, Sardar R.
    Nano Lett; 2014 Dec 10; 14(12):6955-63. PubMed ID: 25379951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.